Showing results (171-180 of 238) with videos related to
Sort By:
Pageof 24
Plos Biology|July 23, 2013
Production of α-galactosylceramide by a prominent member of the human gut microbiotaLaura C Wieland Brown, Cristina Penaranda, Purna C Kashyap, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
NKG2A inhibits invariant NKT cell activation in hepatic injuryToshihiko Kawamura, Kazuyoshi Takeda, Hiroshi Kaneda, et al.Nature Genetics|December 22, 2020
Promoter-interacting expression quantitative trait loci are enriched for functional genetic variantsVivek Chandra, Sourya Bhattacharyya, Benjamin J Schmiedel, et al.European Journal of Immunology|June 18, 2003
Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramideDaniel G Pellicci, Adam P Uldrich, Konstantinos Kyparissoudis, et al.The Journal of Experimental Medicine|December 22, 2004
The role of innate immunity in autoimmunityJean-François Bach, Albert Bendelac, Michael B Brenner, et al.American Journal of Respiratory Cell and Molecular Biology|January 23, 2018
Riboflavin Metabolism Variation among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of Mucosal-associated Invariant T CellsNadine Hartmann, Curtis McMurtrey, Michelle L Sorensen, et al.Cell Discovery|June 19, 2023
Integrative scATAC-seq and scRNA-seq analyses map thymic iNKT cell development and identify Cbfβ for its commitmentJie Wang, Indra Adrianto, Kalpana Subedi, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Mouse TCRalphabeta+CD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responsesTimothy L Denning, Steve W Granger, Steve Granger, et al.Proceedings of the National Academy of Sciences of the United States of America|January 25, 2005
Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cellsDouglass Wu, Guo-Wen Xing, Michael A Poles, et al.Proceedings of the National Academy of Sciences of the United States of America|August 30, 2003
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responsesHiroyoshi Nishikawa, Takuma Kato, Koji Tanida, et al.Pageof 24